Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20.8M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
140M
-
Shares change
-
+3.6M
-
Total reported value, excl. options
-
$1.54B
-
Value change
-
+$32.3M
-
Put/Call ratio
-
0.98
-
Number of buys
-
89
-
Number of sells
-
-83
-
Price
-
$10.96
Significant Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q3 2015
212 filings reported holding NKTR - Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2015.
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 140M shares
.
Largest 10 shareholders include OPPENHEIMER FUNDS INC (26.4M shares), PRIMECAP MANAGEMENT CO/CA/ (19.7M shares), FIRST TRUST ADVISORS LP (10.4M shares), VANGUARD GROUP INC (10.2M shares), BlackRock Fund Advisors (9.79M shares), STATE STREET CORP (4.72M shares), Invesco Ltd. (4.2M shares), MILLENNIUM MANAGEMENT LLC (4.04M shares), FEDERATED INVESTORS INC /PA/ (3.58M shares), and BlackRock Institutional Trust Company, N.A. (3.17M shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.